ARROWHEAD PHARMACEUTICALS, INC. Cash Provided by (Used in) Financing Activities, Discontinued Operations
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Cash Provided by (Used in) Financing Activities, Discontinued Operations of $0 for the 12-month period ending 2014-09-30, per its 10-K filed 2014-11-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations · last filed 2014-11-25
- ARROWHEAD PHARMACEUTICALS, INC. cash provided by (used in) financing activities, discontinued operations for the quarter ending 2010-09-30 was $225.16K.
- ARROWHEAD PHARMACEUTICALS, INC. cash provided by (used in) financing activities, discontinued operations for fiscal 2014 was $0.00.
- ARROWHEAD PHARMACEUTICALS, INC. cash provided by (used in) financing activities, discontinued operations for fiscal 2013 was $0.00.
- ARROWHEAD PHARMACEUTICALS, INC. cash provided by (used in) financing activities, discontinued operations for fiscal 2012 was $0.00.
- ARROWHEAD PHARMACEUTICALS, INC. cash provided by (used in) financing activities, discontinued operations for fiscal 2010 was -$126.53K.
| Period end | Cash Provided by (Used in) Financing Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 12 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 98 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 101 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 104 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 107 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 110 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 113 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 116 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 119 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 122 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 125 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 128 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 131 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-09-30 | $0.00 10-K · filed 2014-11-25 | ||||||||||||||
| 2014-03-31 | -$1.68M 10-Q · filed 2014-05-06 | ||||||||||||||
| 2013-12-31 | -$1.68M 10-Q · filed 2014-02-04 | ||||||||||||||
| 2013-09-30 | $0.00 10-K · filed 2014-11-25 | -$1.68M 10-K · filed 2013-12-18 | |||||||||||||
| 2013-06-30 | -$1.68M 10-Q · filed 2013-08-07 | ||||||||||||||
| 2013-03-31 | -$1.68M 10-Q · filed 2013-05-09 | ||||||||||||||
| 2012-12-31 | -$1.68M 10-Q · filed 2013-02-13 | ||||||||||||||
| 2012-09-30 | $0.00 10-K · filed 2014-11-25 | -$1.68M 10-K · filed 2012-12-28 | |||||||||||||
| 2012-06-30 | -$1.68M 10-Q · filed 2012-08-13 | ||||||||||||||
| 2012-03-31 | -$1.68M 10-Q · filed 2012-05-08 | ||||||||||||||
| 2011-12-31 | -$1.68M 10-Q · filed 2012-02-09 | ||||||||||||||
| 2011-09-30 | -$1.68M 10-Q · filed 2012-08-13 | ||||||||||||||
| 2011-06-30 | -$1.68M 10-Q · filed 2011-08-08 | ||||||||||||||
| 2010-09-30 | $225.16K derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20 | -$126.53K 10-K · filed 2011-12-20 | |||||||||||||
| 2010-06-30 | -$351.69K 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |